Daxor’s BVA-100 blood volume diagnostic expands to three new centers

Daxor announces the expansion of blood volume analysis, BVA. This growth includes launching a BVA program and increasing adoption of Daxor’s ezBVA Lab service – a state-of-the-art CLIA certified facility that provides on-demand, next day blood volume analysis results. The company foresees a strong lineup of developments in the second half of this year, reinforcing its trajectory of accelerated sales growth. “Our unwavering focus on expanding market presence continues to yield strong results. The strategic investments we’ve made in our sales and marketing efforts are clearly bearing fruit,” stated Michael Feldschuh, CEO and President of Daxor. “This growth underscores the increasing recognition of our blood volume analysis technology as a critical tool in improving patient outcomes.”